Literature DB >> 11096196

Why do patients with atopic dermatitis refuse to apply topical corticosteroids?

M Fukaya1.   

Abstract

BACKGROUND: The number of patients with atopic dermatitis who refuse to use topical corticosteroids because of personal fears seems to be increasing. However, studies on this subject are scarce. Consequently, we have investigated this issue further.
METHODS: A cross-sectional study based on a questionnaire. Between September 1998 and January 1999, a questionnaire was distributed to patients who responded to an announcement and to those attending 18 hospitals or clinics and 11 self-help groups throughout Japan to identify what makes patients resistant to applying topical corticosteroids.
RESULTS: Patients who are reluctant to use topical corticosteroids often experienced: ineffective or short-lasting results, adverse side effects and feelings of distrust towards their physician. These feelings of distrust were found to be significantly stronger among patients who were reluctant to apply topical corticosteroids than among patients who accepted the treatment with little or no feelings of resistance. External influences such as those from family members, acquaintances, mass media (television, newspapers and magazines), alternative 'nondoctor' therapists and self-help groups were not found to be a significant factor between both groups. However, the influence of the physician was found to be significant and directly related to the patients' lack of trust.
CONCLUSIONS: Patients with atopic dermatitis who refuse to use topical corticosteroids attribute their feelings of resistance to personal experiences rather than to information from external sources. Information or warnings about associated side effects from physicians may help to reduce these fears and ultimately benefit the physician-patient relationship.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096196     DOI: 10.1159/000018495

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  8 in total

1.  Inhibitory Effects of Donkey Hide Gelatin on DNCB-Induced Atopic Dermatitis in NC/Nga Mice.

Authors:  Ju Hyun Lee; Linsha Dong; Hyeon Min Noh; Sung-Gu Park; Seung-Hyung Kim; Eun Heui Jo; Dong-Sung Lee; Min Cheol Park
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

2.  Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids.

Authors:  Hyun Jung Kim; Hyun Jung Park; Jae Nam Yun; Se Kyoo Jeong; Sung Ku Ahn; Seung Hun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

3.  Patient-reported outcomes after discontinuation of long-term topical corticosteroid treatment for atopic dermatitis: a targeted cross-sectional survey.

Authors:  Naoko Takahashi-Ando; Mark A Jones; Shigeki Fujisawa; Rokuro Hama
Journal:  Drug Healthc Patient Saf       Date:  2015-04-07

4.  Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea.

Authors:  Jin Yong Lee; Young Her; Chul Woo Kim; Sang Seok Kim
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

5.  Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Ju Hyun Lee; Eun Heui Jo; Jee Youn Jung; Young-Eun Kim; Mi-Ju Son; Su Jin Kang; Geum Jin Yang; Yu Hwa Shim; Min Cheol Park
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

Review 6.  Treatment of eczema.

Authors:  Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 10.817

7.  TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.

Authors:  Leïla Moret; Emmanuelle Anthoine; Hélène Aubert-Wastiaux; Anne Le Rhun; Christophe Leux; Juliette Mazereeuw-Hautier; Jean-François Stalder; Sébastien Barbarot
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

8.  Parents' and carers' views about emollients for childhood eczema: qualitative interview study.

Authors:  M Santer; I Muller; L Yardley; S Lewis-Jones; S Ersser; P Little
Journal:  BMJ Open       Date:  2016-08-19       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.